MedTrace Logo

NanoSpectrometer Biomarker Discovery and Confirmation Study

NCT03275688 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 332

Last updated 2020-07-22

No results posted yet for this study

Summary

This study will evaluate exhaled volatile organic compounds (VOC's) in the breath of participants with stage 1 lung cancer, their house-mates, and matched controls. The goal of the study is to identify VOC fingerprints that are only detectable in those with stage 1 lung cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

Breath Analysis

Breath will be analyzed in all three groups using gas chromatography mass spectrometry.

Sponsors & Collaborators

Principal Investigators

  • Lonny Yarmus, DO · Johns Hopkins University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-05
Primary Completion
2020-07-06
Completion
2020-07-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03275688 on ClinicalTrials.gov